# Apixaban

## ELIQUIS 5mg

| 藥物代碼 | OELI |
| :--- | :--- |
| 適應症 | Prevention of stroke & systemic embolism in adult patients with non-valvular atrial fibrillation \(NVAF\), w/ &gt;=1 risk factors \[eg, prior stroke or transient ischaemic attack, age &gt;=75 yr, HTN, DM, symptomatic heart failure \(NYHA class &gt;=II\)\]. Prevention of venous thromboembolic events \(VTE\) in adult patients who have undergone elective hip or knee replacement surgery. Treatment of deep vein thrombosis \(DVT\) & pulmonary embolism \(PE\); prevention of recurrent DVT & PE in adult patients. |
| 副作用 | Epistaxis, anaemia, nausea, contusion, haematuria, haematoma, vag & urethral haemorrhage; eye, GI & rectal haemorrhage; gingival bleeding. |
| 禁忌 | Hypersensitivity. Clinically significant active bleeding. Hepatic disease associated w/ coagulopathy & clinically relevant bleeding risk. Lesion or condition at significant risk of major bleeding \(eg, current or recent GI ulceration, presence of malignant neoplasms at high risk of bleeding; recent brain/spinal injury, brain/spinal/ophth surgery, intracranial haemorrhage; known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. Concomitant treatment w/ any other anticoagulant eg, unfractionated heparin \(UFH\), low molecular wt heparins, heparin derivatives, oral anticoagulants except under the circumstances of switching therapy to or from apixaban or when UFH is given at doses necessary to maintain a patent central venous or arterial catheter. |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | 上方欄位懷孕用藥危險分級藥品 B 級的參考依據為藥品仿單。 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity\(Mother\) 無\(很少\)資料 - 避免使用\(母體\) |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

